FAL
LLY icon

Focused Alpha LLC’s Eli Lilly LLY Stock Holding History

Focused Alpha LLC’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$486K Sell
406
-369
-48% -$377K 0.12% 155
2026
Q1 		$713K Buy
775
+102
+15% +$103K 0.22% 97
2025
Q4 		$723K Buy
+673
New +$644K 0.21% 94

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Focused Alpha LLC's LLY Position: Q2 2026 in Review

Focused Alpha LLC reduced its Eli Lilly (LLY) stake by 48% in Q2 2026, selling an estimated $377K and leaving 406 shares worth $486K. The position accounts for 0.12% of the portfolio, ranked #155.

Focused Alpha LLC first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. The position peaked at $723K in Q4 2025. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Focused Alpha LLC held 406 shares of Eli Lilly worth $486K as of Q2 2026.
  • Focused Alpha LLC sold 369 Eli Lilly shares in Q2 2026, an estimated $377K.
  • Eli Lilly made up 0.12% of Focused Alpha LLC's portfolio in Q2 2026, its #155 holding.
  • Focused Alpha LLC first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • Focused Alpha LLC's Eli Lilly position peaked at $723K in Q4 2025.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Focused Alpha LLC's 13F filing for Q2 2026, filed 7 Aug 2026.